Minerva Neurosciences Stock Filter Stocks by Fundamentals
| NERV Stock | USD 2.26 0.11 5.12% |
Minerva Neurosciences fundamentals help investors to digest information that contributes to Minerva Neurosciences' financial success or failures. It also enables traders to predict the movement of Minerva Stock. The fundamental analysis module provides a way to measure Minerva Neurosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Minerva Neurosciences stock.
Minerva | Shares Owned by Insiders |
Minerva Neurosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Minerva Neurosciences from analyzing Minerva Neurosciences' financial statements. These drivers represent accounts that assess Minerva Neurosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Minerva Neurosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 277.4M | 95.5M | 34.2M | 8.5M | 40.0M | 38.0M | |
| Enterprise Value | 256.3M | 70.3M | (26.5M) | 46.1M | 81.1M | 127.3M |
Minerva Neurosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Minerva Neurosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Minerva Neurosciences' managers, analysts, and investors.Environmental | Governance | Social |
Minerva Neurosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Minerva Neurosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Minerva Neurosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Minerva Neurosciences' value.| Shares | Tower Research Capital Llc | 2024-06-30 | 2.4 K | Wells Fargo & Co | 2024-06-30 | 1.9 K | Royal Bank Of Canada | 2024-06-30 | 1.8 K | Acadian Asset Management Llc | 2024-06-30 | 1.2 K | Tfc Financial Management | 2024-09-30 | 186 | Bank Of America Corp | 2024-06-30 | 169 | Sandy Spring Bank | 2024-06-30 | 100.0 | Northwestern Mutual Wealth Management Co | 2024-06-30 | 100.0 | Ubs Group Ag | 2024-06-30 | 10.0 | Federated Hermes Inc | 2024-09-30 | 1.4 M | Vanguard Group Inc | 2024-09-30 | 252.1 K |
Minerva Fundamentals
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (10.76 M) | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 22.26 % | ||||
| Shares Owned By Institutions | 30.47 % | ||||
| Number Of Shares Shorted | 23.38 K | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X | ||||
| Gross Profit | (16.84 M) | ||||
| EBITDA | (21.69 M) | ||||
| Net Income | (30.01 M) | ||||
| Cash And Equivalents | 40.22 M | ||||
| Cash Per Share | 7.53 X | ||||
| Total Debt | 82.02 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 20.41 X | ||||
| Book Value Per Share | (3.10) X | ||||
| Cash Flow From Operations | (14.78 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 5.0 | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 15.77 M | ||||
| Total Asset | 56.9 M | ||||
| Retained Earnings | (396.82 M) | ||||
| Working Capital | 38.66 M | ||||
| Current Asset | 33.48 M | ||||
| Current Liabilities | 5.32 M | ||||
| Net Asset | 56.9 M |
About Minerva Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.